Speaker illustration

Associate Professor David Peter Kao

University of Colorado Denver, Denver (United States of America)

Member of:

European Society of Cardiology
Heart Failure Association

Latent class analysis of echocardiographic phenotypes predicts adverse outcomes and treatment response in heart failure with preserved ejection fraction

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Spironolactone reduces all-cause mortality in women but not men with heart failure with preserved ejection fraction enrolled in TOPCAT from the Americas

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: Moderated Poster session 6 - Therapy

Thumbnail

Heart rate reduction or ventricular reverse remodeling associated with beta-blocker therapy is accompanied widespread, distinct changes in the beta1-adrenergic receptor gene signaling network

Event: HEART FAILURE 2016

Topic: Beta blockers

Session: Beta blockers

Thumbnail

Association of anemia and transfusion with adverse outcomes in 22,991 patients hospitalized with takostsubo cardiomyopathy

Event: HEART FAILURE 2016

Topic: Cardiomyopathies

Session: Cardiomyopathy

Thumbnail

Race differences in timing of presentation in 1137 peripartum cardiomyopathy patients compared with 2.1 million delivering mothers without peripartum cardiomyopathy

Event: HEART FAILURE 2016

Topic: Cardiomyopathies

Session: Cardiomyopathy

Thumbnail

This platform is supported by

logo Novo Nordisk